Kalydeco Interactions
There are 420 drugs known to interact with Kalydeco (ivacaftor), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 72 are major, 330 are moderate, and 18 are minor.
- View all 420 medications that may interact with Kalydeco
- View Kalydeco alcohol/food interactions (1)
- View Kalydeco disease interactions (3)
Most frequently checked interactions
View interaction reports for Kalydeco (ivacaftor) and the medicines listed below.
- Actemra (tocilizumab)
- Advate (antihemophilic factor)
- Avastin (bevacizumab)
- azithromycin
- Baraclude (entecavir)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- Cayston (aztreonam)
- Creon (pancrelipase)
- Diacomit (stiripentol)
- Enbrel (etanercept)
- Esbriet (pirfenidone)
- Imbruvica (ibrutinib)
- Isentress (raltegravir)
- Matulane (procarbazine)
- Norvir (ritonavir)
- Ofev (nintedanib)
- Oncovin (vincristine)
- prednisone
- Procysbi (cysteamine)
- Pulmozyme (dornase alfa)
- Ravicti (glycerol phenylbutyrate)
- Rescriptor (delavirdine)
- Revlimid (lenalidomide)
- Singulair (montelukast)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Symdeko (ivacaftor / tezacaftor)
- Tecentriq (atezolizumab)
- Thalomid (thalidomide)
Kalydeco alcohol/food interactions
There is 1 alcohol/food interaction with Kalydeco (ivacaftor).
Kalydeco disease interactions
There are 3 disease interactions with Kalydeco (ivacaftor) which include:
More about Kalydeco (ivacaftor)
- Kalydeco consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CFTR potentiators
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.